Immune to Cancer: The CRI Blog
-
Shirley Dumont’s Immunotherapy Story
Bladder Cancer | Diagnosed 2008 My doctor calls me the ‘bionic woman.’ This is all through immunotherapy. Shirley’s… -
CRI Hosts Academic and Industry Experts for “Immuno-Oncology: A Future Look”
CRI hosted its inaugural “Immuno-Oncology: A Future Look” event for healthcare investment analysts and media on June…
-
Watch and Learn – “Immuno-Oncology: A Future Look” Event Video Recording
Watch the full video recording of June 21’s Immuno-Oncology: A Future Look event, featuring Drs. Jim Allison,…
-
MUFG Pedal to the Medal: CRI Cycling Challenge
Fifty-five employees from the MUFG came together for the second annual “Pedal to the Medal: CRI Cycling Challenge,” a…
-
Speaking With Your Oncologist: The Importance of Building Trust and Open Dialogue
Brendan Connors and his oncologist, Michael Postow, MD, reunited for a special Cancer Immunotherapy Month webinar to…
-
Riding with a Purpose: Answer to Cancer Studio Cycling Event
At the second annual Answer to Cancer studio cycling event hosted by the CRI Associate Board, 36 dedicated…
-
CRI Celebrates a Future #Immune2Cancer on June 14 – Wear White Day
Supporters, scientists, patients, and advocates participated in CRI’s annual Wear White Day for a Future Immune to…
-
“Cancer Immunotherapy Insights from ASCO” Twitter Chat Recap #CIMchat
CRI hosted a Twitter Chat, moderated by STAT’s Sharon Begley, discussing takeaways from the ASCO19 conference last…
-
ASCO19 Recap: Caring for Every Patient, Learning from Every Patient
ASCO19 highlighted a number of immunotherapy developments, including those relating to long-term survival, introducing immunotherapy earlier, biomarkers,…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.